ATCC has updated the White Paper Synthetic Nucleic Acids for the Development and Evaluation of In Vitro Diagnostic Devices Designed to Detect Dengue, Chikungunya, and Zika White Paper.
About Us
In Vitro Technologies Life Sciences division has a long history of supporting the Australian research community reaching back to 1958 and has developed a reputation for being one of the most dynamic and successful life science suppliers throughout Australia and New Zealand.
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand. Our range of cells, consumables, reagents, and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes & Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
All news
Latest News
Feb 26, 2018
Eradicate Cancer Travel Grant Winners
To support Australian and New Zealand research in the fight against cancer, In Vitro Technologies offered 5 Travel Grants to Australian and New Zealand researchers to attend the Eradicate Cancer Conference in Melbourne in March 2018. And the winners are...
Jan 18, 2018
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Great publication about improving the efficacy of adoptive T-Cell therapy in solid tumours by using 3rd generation CAR-T cells.
Dec 11, 2017
Oncolytic Adenovirus Expressing BiTE Effectively Recruits T Cells to Kill Diverse Cancer Cell Types
Scientists at the University of Oxford have described a new twist on cancer immunotherapy, combining two independent cell killing approaches in a single therapeutic with high potency and broad applicability.
